What We Do
Prometic is a biopharmaceutical corporation with two drug discovery platforms focusing on rare diseases and unmet medical needs. The first platform (small molecule therapeutics) stems from the discovery of two receptors which we believe are at the core of how the body heals: namely, promoting tissue regeneration and scar resolution as opposed to fibrosis. Our small molecule lead drug candidate, PBI-4050, is expected to enter pivotal phase 3 clinical trials for the treatment of Idiopathic Pulmonary Fibrosis (IPF). The second drug discovery and development platform (plasma-derived therapeutics) leverages Prometic’s experience in bioseparation technologies used to isolate and purify biopharmaceuticals from human plasma to address unmet medical needs with therapeutic proteins not currently commercially available, such as Ryplazim™ (plasminogen).
Prometic is headquartered in Laval, Quebec (Canada), has R&D facilities in Canada, the United Kingdom (“UK”) and the United States (“USA”), manufacturing facilities in Canada and the Isle of Man and corporate and business development activities in Canada, the USA, Europe and Asia.
Why You Should Join
Prometic Drives A Culture Of Innovation
We are constantly discovering new innovations for the development of best in class products and orphan drugs that target unmet medical conditions and rare diseases. We do it not because we have to but because we are compelled to. It’s at the heart of our culture to provide a pathway to hope.
Diversity & Community
Prometic is an equal opportunity employer and has opportunities globally for hardworking passionate people in research, development, manufacturing and marketing. We believe breakthrough therapeutics can best be discovered and brought to fruition when teams are inclusive and diverse.